FIELD: medicine.
SUBSTANCE: group of inventions relates to biology and medicine and concerns a novel composition of polypeptides recovered from bovine cerebrum cortex extract, a pharmaceutical composition based on said polypeptides and use thereof. Polypeptide composition has nootropic, neuroprotective, antioxidant, tissue-specific action and is characterized by the following values: molecular weight of polypeptides is approximately 8300–8500 Da; amount of bound amino acids is: arginine - 19 to 52 mcg/mg, glycine - 22 to 32 mcg/mg, asparagine - 107 to 138 mcg/mg, glutamine - 117 to 206 mcg/mg, alanine - 29 to 50 mcg/mg, proline - 52 to 70 mcg/mg, lysine - 50 to 83 mcg/mg, leucine - 34 to 56 mcg/mg of the dry residue of the composition. Pharmaceutical composition for normalizing cerebral function comprises said polypeptide composition and a pharmaceutically acceptable carrier. Also disclosed is the use of the above compositions for relieving convulsive syndrome, recovering disturbed cerebral reflex activity, memory, coordination of motions, stroke, cerebral effusions or as neuroprotector.
EFFECT: composition of polypeptides has the properties of normalizing cerebral function, and has less side effects compared to the prototype when used.
11 cl, 5 dwg, 12 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
POLYPEPTIDE COMPOSITION HAVING PROPERTY OF NORMALIZING CEREBRAL FUNCTIONS | 2019 |
|
RU2727167C1 |
POLYPEPTIDE COMPOSITION HAVING PROPERTY OF NORMALIZING CEREBRAL FUNCTIONS | 2019 |
|
RU2726854C1 |
POLYPEPTIDE COMPOSITION HAVING PROPERTY OF NORMALIZING CEREBRAL FUNCTIONS | 2019 |
|
RU2727162C1 |
POLYPEPTIDE COMPOSITION HAVING PROPERTY OF NORMALIZING CEREBRAL FUNCTIONS | 2019 |
|
RU2727159C1 |
POLYPEPTIDE COMPOSITION HAVING PROPERTY OF NORMALIZING CEREBRAL FUNCTIONS | 2019 |
|
RU2727586C1 |
PROTEIN-POLYPEPTIDE COMPLEX POSSESSING ANTIHYPOXIC, TISSUE-SPECIFIC REPARATIVE ACTION ON CENTRAL AND PERIPHERAL NERVOUS SYSTEMS, METHOD FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITION THEREOF | 2011 |
|
RU2485132C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISORDERS OF CARDIOVASCULAR, TRAUMATIC, TOXIC, HYPOXIC AND AUTOIMMUNE GENESIS | 2010 |
|
RU2445106C1 |
METHOD FOR PREPARING BIOLOGICALLY ACTIVE COMPLEX AND BIOLOGICALLY ACTIVE PROTEIN-POLYPEPTIDE COMPLEX | 2010 |
|
RU2428196C1 |
METHOD OF TREATING ACUTE ISCHEMIC AND HEMORRHAGIC CEREBROVASCULAR DISEASE | 2010 |
|
RU2477637C2 |
PEPTIDE WITH NEUROSTIMULATION ACTIVITY AND RESTORE LEARNING AND MEMORY FORMATION, PHARMACEUTICAL COMPOSITION ON ITS BASIS AND METHOD FOR ITS APPLICATION | 2021 |
|
RU2768475C1 |
Authors
Dates
2020-07-21—Published
2019-09-17—Filed